Cray And Markley Partner To Provide Supercomputing As A Service
By Bio-IT World Staff
May 22, 2017 | Cray and Markley have announced a partnership to provide supercomputing as a service solutions that combine the power of Cray supercomputers with the premier hosting capabilities of Markley. Through the partnership, Markley will offer Cray supercomputing technologies, as a hosted offering, and both companies will collaborate to build and develop industry-specific solutions.
The availability of sought-after supercomputing capabilities both on-premises and in the cloud has become increasingly desirable across a range of industries, including life sciences, bio-pharma, aerospace, government, banking, and more – as organizations work to analyze complex data sets and research, and reduce time to market for new products. Through the new supercomputing as a service offering, Cray and Markley will make it easier and more affordable for research scientists, data scientists, and IT executives to access dedicated, powerful compute and analytic capability to increase time to discovery and decision.
Headquartered in Boston, Markley delivers best-of-breed cloud and data center offerings, including its enterprise-class, on-demand Infrastructure-as-a-Service solution that helps organizations maximize IT performance, reduce upfront capital expenses, increase speed to market, and improve business continuity. In addition, Markley guarantees 100% uptime, backed by the industry’s best Service Level Agreement.
The first industry solution built by Cray and hosted by Markley will feature the Cray Urika-GX for life sciences – a complete, pre-integrated hardware-software solution. In addition, Cray has integrated the Cray Graph Engine (CGE) with essential pattern-matching capability and tuned it to leverage the highly-scalable parallelization and performance of the Urika-GX platform. Cray and Markley have plans for the collaboration to quickly expand and include Cray’s full range of infrastructure solutions.
“Research and development, particularly within life sciences, biotech, and pharmaceutical companies, is increasingly data driven. Advances in genome sequencing technology mean that the sheer volume of data and analysis continues to strain legacy infrastructures,” wrote Chris Dwan, who led research computing at both the Broad Institute and the New York Genome Center. “The shortest path to breakthroughs in medicine is to put the very best technologies in the hands of the researchers, on their own schedule. Combining the strengths of Cray and Markley into supercomputing as a service does exactly that.”
Cray will be exhibiting at the 15th annual Bio-IT World Conference & Expo May 23-25, 2017.